本页面由Tiger Trade Technology Pte. Ltd.提供服务

Autolus Therapeutics PLC

1.62
-0.1200-6.90%
盘后:1.620.00000.00%16:00 EDT
成交量:241.33万
成交额:397.25万
市值:4.31亿
市盈率:-1.54
高:1.74
开:1.74
低:1.60
收:1.74
52周最高:2.58
52周最低:1.18
股本:2.66亿
流通股本:1.03亿
量比:1.63
换手率:2.34%
股息:- -
股息率:- -
每股收益(TTM):-1.0526
每股收益(LYR):-1.0804
净资产收益率:-133.00%
总资产收益率:-25.44%
市净率:5.76
市盈率(LYR):-1.50

数据加载中...

2023/12/11

重要事件披露

Form 8-K - Current report
2023/11/27

重要事件披露

Form 8-K - Current report
2023/11/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/09

重要事件披露

Form 8-K - Current report
2023/11/03

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/08/08

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/07/10

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/03/20

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/03/07

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/12/19

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/12/13

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/12/13

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/10/05

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/05/13

SEC问询函

CORRESP [Cover] - Correspondence